title: Should the American Society of Clinical Oncology Ask for Peer Review Before Publishing Its Advocacy Research?
authors.affiliation: Peter B. Bach, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Peter B
authors.initials: PB
authors.lastname: Bach
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D000068598:Data Accuracy; D016527:Drug Costs; D006302:Health Services Research / Q000592:standards; D006801:Humans; D007349:Insurance, Health, Reimbursement; D008495:Medical Oncology / Q000592:standards; D016345:Medicare Part B; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics; D010344:Patient Advocacy / Q000592:standards; D017712:Peer Review, Research / Q000592:standards; D010506:Periodicals as Topic / Q000592:standards; D011786:Quality Control; D014481:United States
chemical_list: D000970:Antineoplastic Agents